CSPC Pharmaceutical Group Limited. 

$1.1200
52
-$0.14-11.11%星期一 21:00

統計

當日最高
1.26
當日最低
1.26
52週高點
1.39
52週低點
0.94
成交量
2,000
平均成交量
89
市值
12.91B
本益比
27.8
股息殖利率
4.1%
股息
0.05

即將到來

股息

4.1%股息殖利率
2026年11月
$0.02
2026年7月
$0.02
2025年11月
$0.02
2025年7月
$0.01
2024年11月
$0.02
10年成長
27.03%
5年成長
13.98%
3年成長
9.63%
1年成長
36.94%

財報

9月30日預期
Q3 2022
Q4 2023
Q2 2024
Q1 2025
Q2 2025
Q4 2025
Q2 2026
0.03
0.06
0.1
0.13
預期EPS
不適用
實際EPS
不適用

財務

14.88%利潤率
有盈利
2020
2021
2022
2023
2024
2025
3.67B營收
546.38M淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 CHJTF 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

CSPC Pharmaceutical Group Limited, primarily an investment holding entity, is dedicated to the development, production, and distribution of pharmaceutical goods. Its operations span the globe, with a significant presence in the People's Republic of China, across Asia, in the Americas, and throughout Europe. The company structures its business activities into three main divisions: Finished Drugs, Bulk Products, and Functional Food and Other ventures. The company's extensive portfolio of finished drugs encompasses treatments for a wide range of conditions. Key offerings include NBP (available as soft capsules and injections) for acute ischemic stroke, and Oulaining (capsules and injections) addressing mild to moderate memory and cognitive impairments. For neurological disorders, Enxi targets adult idiopathic Parkinson's disease. In oncology, Duomeisu treats lymphoma, multiple myeloma, ovarian and breast cancers, alongside other malignant tumors, while Jinyouli aids in preventing chemotherapy-induced leucopenia and infections, and Keaili is prescribed for breast cancer. Further therapeutic areas covered by CSPC include various infections, with products such as Shuluoke, Nuomoling, Weihong, and Xinweihong. Cardiovascular health is addressed by Xuanning for hypertension and Encun to avert atherosclerotic thrombosis events. Qixiao provides relief for upper respiratory tract infections, and diabetes management is supported by Linmeixin and Shuanglexin. Bone health solutions include Gubang and Gubangjia for postmenopausal osteoporosis. Additionally, Gaoshunsong offers relief for a broad spectrum of inflammatory and pain-related conditions, including arthritis, osteoarthritis, ankylosing spondylitis, frozen shoulder, bursitis, tenosynovitis, acute gout, dysmenorrhea, toothache, postoperative pain, lower back pain, sprains, strains, and other soft tissue injuries. Other notable products include Debixin for various types of ulcers and Qimaite for acute and chronic pain management. Beyond finished pharmaceuticals, CSPC also supplies active pharmaceutical ingredients (APIs) like antibiotics, vitamin C, and caffeine. The company further diversifies into functional foods, glucose products, and provides healthcare services. Originally established in 1992, the company initially operated under the name China Pharmaceutical Group Limited before adopting its current designation, CSPC Pharmaceutical Group Limited, in March 2013. Its primary corporate office is situated in Shijiazhuang, within the People's Republic of China.
顯示更多
執行長
Lei Cai
員工
18626
國家
香港
ISIN
HK1093012172
WKN
000548183

上市

0 則留言

分享你的想法

常見問題

CSPC Pharmaceutical Group Limited. 今天的股價是多少?▼
CHJTF 目前價格為 $1.12 USD,過去 24 小時下跌了 -11.11%。在圖表上更密切關注 CSPC Pharmaceutical Group Limited. 股票的表現。
CSPC Pharmaceutical Group Limited. 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 OTC Link 交易所,CSPC Pharmaceutical Group Limited. 的股票以代號 CHJTF 進行交易。
CSPC Pharmaceutical Group Limited. 的股價在上漲嗎?▼
CHJTF 股票較上週下跌 -11.11%,本月下跌 -11.11%,但在過去一年中,CSPC Pharmaceutical Group Limited. 上漲了 +17.89%。
CSPC Pharmaceutical Group Limited. 的市值是多少?▼
今天 CSPC Pharmaceutical Group Limited. 的市值為 12.91B
CSPC Pharmaceutical Group Limited. 下一次財報日期是什麼時候?▼
CSPC Pharmaceutical Group Limited. 將於 2027年3月3日 公布下一次財報。
CSPC Pharmaceutical Group Limited. 去年的營收是多少?▼
CSPC Pharmaceutical Group Limited. 去年的營收為 3.67BUSD。
CSPC Pharmaceutical Group Limited. 去年的淨利是多少?▼
CHJTF 去年的淨收益為 546.38MUSD。
CSPC Pharmaceutical Group Limited. 會發放股息嗎?▼
是的,CHJTF 的股息每 半年一次 發放一次。每股最新股息為 0.02 。截至今日,股息殖利率(FWD)% 為 4.1%。
CSPC Pharmaceutical Group Limited. 有多少名員工?▼
截至 2026年11月21日,公司共有 18,626 名員工。
CSPC Pharmaceutical Group Limited. 位於哪個產業?▼
CSPC Pharmaceutical Group Limited.從事於Health & Wellness產業。
CSPC Pharmaceutical Group Limited. 何時完成拆股?▼
CSPC Pharmaceutical Group Limited. 上次拆股發生於 2020年11月16日,比例為 1.6:1。
CSPC Pharmaceutical Group Limited. 的總部在哪裡?▼
CSPC Pharmaceutical Group Limited. 的總部位於 香港 的 Shijiazhuang。